age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
72.95599
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 0
| 16,094
| 9,747.75
| null | 16.5
|
white
| 31.597656
| 51
| 0.629883
| 0.526978
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 9
| 42
| 5.699219
| 80
| 24
| 37.5
| 359.25
| 3.899902
| 1.099854
| 8.099609
| 135
| 7.439453
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 965
| 1
|
30.021
|
female
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
| null | 0
| 257,474
| 150,595.625
| null | 35.333313
|
white
| 26.898438
| 43
| 0.813965
| 0.751953
| 80
| 0
| 0
|
no
| 0.3
| 0.4
|
dnr after sadm
| 20
| 73
| 0.199982
| 104
| 32
| 38.19531
| null | 2.399902
| null | 0.699951
| 141
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
66.72699
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
| null | 0
| 57,971
| 30,666.6406
| null | 15.666664
|
white
| 31.699219
| 42
| 0.661987
| 0.564941
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 25
| 69
| 5.199219
| 52
| 28
| 36.39844
| 169.375
| 3.199707
| null | 4.799805
| 145
| 7.349609
| null | null | null | 2
| 1
|
no(M2 and SIP pres)
| 1
| 1,590
| 0
|
72.45996
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 21,265
| 6,894.4297
| null | 32.5
|
white
| 32.09375
| 62
| 0.619995
| 0.515991
| 1
| 0
| 1
|
no
| 0.2
| 0.15
|
dnr after sadm
| 3
| 43
| 21.5
| 111
| 42
| 38.69531
| 275
| 2.399902
| 0.099991
| 0.799927
| 144
| 7.289062
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 10
| 1
|
59.737
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 8,897
| 5,825.3672
| null | 13
|
white
| 24.597656
| 21
| 0.543945
| 0.220978
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.7
|
no dnr
| 5
| 117
| 6.5
| 120
| 25
| 36.09375
| null | 3.199707
| null | 1
| 139
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
75.28497
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 9
| 63,906
| 40,457
| null | 52
|
white
| 38.898438
| 46
| 0.240997
| 0.138977
| 24
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 1
| 49
| 16.097656
| 116
| 28
| 35.79688
| 163.25
| 2.699707
| 1.599854
| 1.699951
| 149
| 7.449219
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 6
| 1
|
60.46799
|
male
| 1
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 110,493
| null | null | 46.666657
|
white
| 43.5
| 66
| 0.087997
| 0.034996
| 22
| 0
| 0
|
yes
| 0.02
| 0.000008
|
dnr after sadm
| 20
| 49
| 36.195313
| 116
| 10
| 35.39844
| 142.84375
| 2.399902
| 1.899902
| 6.099609
| 148
| 7.279297
| null | null | null | null | null |
<2 mo. follow-up
| 2.036133
| 21
| 1
|
86.17096
|
female
| 0
| 95
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 215,811
| 79,855.875
| null | 40.25
|
white
| 34.695313
| 42
| 0.414978
| 0.294983
| 3
| 0
| 0
|
no
| 0.7
| 0.9
|
no dnr
| 95
| 50
| 12.599609
| 38
| 24
| 38.89844
| 96.65625
| 3.199707
| 0.799927
| 0.799927
| 137
| 7.419922
| null | null | null | null | null | null | 3.432617
| 1,583
| 0
|
79.98395
|
male
| 1
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
|
>$50k
| 0
| 18,895
| 7,076.6055
| null | 45
|
white
| 42.398438
| 68
| 0.220978
| 0.071991
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 6
| 45
| 11.699219
| 150
| 35
| 35.89844
| 213.3125
| 2.399902
| 0.799927
| 1.699951
| 138
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
53.65598
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 16,865
| 9,048.6797
| null | 14.5
|
hispanic
| 20.898438
| 47
| 0.875
| 0.830933
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 11
| 60
| 9.699219
| 69
| 40
| 38.89844
| null | 2.299805
| 2.899902
| 1.399902
| 132
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,580
| 0
|
67.51794
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 23,680
| 17,051.9375
| null | 9
|
white
| 29.097656
| 58
| 0.711914
| 0.623901
| 1
| 1
| 1
|
no
| 1
| 0.1
|
no dnr
| 18
| 78
| 12
| 100
| 38
| 37.59375
| 93
| 3
| 3.299805
| 1.5
| 137
| 7.349609
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,579
| 0
|
83.50696
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 2
| 12
| null | 0
| 8,183
| 5,498.0977
| null | 8
|
white
| 6.299805
| 18
| 0.900879
| 0.772949
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 7
| 103
| 6.899414
| 60
| 20
| 36.09375
| null | 4.399414
| 0.699951
| 1.199951
| 138
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,579
| 0
|
68.22198
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 4,646
| 3,037.4551
| null | 15
|
white
| 16.296875
| 26
| 0.887939
| 0.813965
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 80
| 7.399414
| 90
| 25
| 36.19531
| null | 4
| null | 1.699951
| 141
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,578
| 0
|
64.72296
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 20,184
| 9,861.875
| null | 16.5
|
white
| 30.699219
| 39
| 0.709961
| 0.549927
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 13
| 57
| 14.699219
| 101
| 36
| 36.19531
| 116.3125
| 3
| 0.5
| 0.799927
| 136
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,257
| 1
|
87.04199
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 9
| 17,585
| 8,647.2109
| null | 18
|
white
| 36.398438
| 72
| 0.360962
| 0.242981
| 1
| 0
| 1
|
no
| 0.7
| 0.5
|
no dnr
| 13
| 52
| 17
| 116
| 30
| 37.89844
| 125.70312
| 2.799805
| 0.299988
| 2.399902
| 145
| 7.449219
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 150
| 1
|
81.85895
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 9
| 25,693
| 18,750.5312
| null | 15.333328
|
white
| 19.398438
| 20
| 0.792969
| 0.724976
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 15
| 110
| 10.898438
| 110
| 14
| 37.79688
| 240
| null | null | 0.799927
| 143
| 7.40918
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 1,467
| 1
|
74.61694
|
female
| 1
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 9
| 19,026
| 6,393.8477
| null | 13
|
white
| 19.796875
| 43
| 0.796997
| 0.672974
| 1
| 0
| 1
|
no
| 0.5
| 0.3
|
dnr after sadm
| 8
| 65
| 12.898438
| 120
| 35
| 36.59375
| 262.5
| null | 0.699951
| 0.599976
| 141
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 5.261719
| 9
| 1
|
53.59299
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 15
| null | 0
| 7,058
| 4,624.3828
| null | 15
|
white
| 10
| 14
| 0.838989
| 0.647949
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 6
| 103
| 13.699219
| 100
| 20
| 36.79688
| null | 4.099609
| 0.299988
| 1
| 141
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,344
| 1
|
57.84497
|
male
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 29,955
| 20,794.0781
| null | 16
|
white
| 23
| 28
| 0.850952
| 0.753906
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 22
| 80
| 4.899414
| 127
| 25
| 35.89844
| 342.8125
| 3.699707
| 2.099609
| 1.199951
| 146
| 7.399414
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 774
| 1
|
78.60596
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 18
| null | 0
| 18,683
| 11,155.7188
| null | 11.666664
|
white
| 20.097656
| 28
| 0.815918
| 0.754883
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 15
| 109
| 11.5
| 73
| 26
| 39.69531
| null | 4
| 1.099854
| 1.399902
| 133
| null | null | null | null | 1
| 5
|
no(M2 and SIP pres)
| 5
| 1,550
| 1
|
43.38898
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 25,196
| 13,795.8359
| null | 13.333328
|
black
| 19.398438
| 20
| 0.907959
| 0.875
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 17
| 65
| 6.099609
| 110
| 20
| 37.89844
| 420
| 3.199707
| 1.399902
| 0.699951
| 139
| 7.389648
| null | null | null | 0
| 0
| null | 0
| 1,568
| 0
|
59.34799
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
>$50k
| 0
| 29,852
| 14,541.1406
| null | 20
|
white
| 30
| 31
| 0.671997
| 0.575928
| 1
| 0
| 0
|
yes
| 0.3
| 0.1
|
no dnr
| 18
| 55
| 13.199219
| 68
| 13
| 35.59375
| 128.3125
| 3.699707
| 1.299805
| 0.899902
| 140
| 7.459961
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 113
| 1
|
78.67798
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
| null | 37
| 19,026
| 6,859.6016
| null | 37.5
|
white
| 21.398438
| 49
| 0.679932
| 0.585938
| 1
| 1
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 7
| 59
| 7.399414
| 60
| 8
| 37.69531
| 390
| 2.099609
| 0.699951
| 3.5
| 147
| 7.439453
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
75.52899
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 13,975
| 9,379.8125
| null | 12
|
white
| 18.5
| 38
| 0.846924
| 0.747925
| 1
| 0
| 0
|
no
| 0.2
| 0.5
|
no dnr
| 13
| 73
| 4.199219
| 80
| 20
| 37
| 224
| null | null | 2.399902
| 136
| 7.479492
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,570
| 0
|
47.59198
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 0
| 57,841
| 33,688.0625
| null | 19.75
|
white
| 27
| 34
| 0.822998
| 0.763916
| 1
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 27
| 113
| 22.296875
| 136
| 10
| 39.39844
| 275.5
| 2.5
| 2
| 2
| 147
| 7.349609
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,570
| 0
|
82.63696
|
female
| 0
| 88
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 15
|
under $11k
| 0
| 87,279
| 55,067.1875
| null | 8.75
|
white
| 15.298828
| 34
| 0.794922
| 0.670898
| 6
| 0
| 0
|
no
| 0.85
| 0.8
|
dnr after sadm
| 1
| 60
| 9.099609
| 74
| 34
| 36.5
| 192.5625
| 3.799805
| 0.5
| 0.899902
| 139
| 7.489258
| null | null | null | 2
| null |
adl>=4 (>=5 if sur)
| 1.839
| 137
| 1
|
68.87097
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 12
|
under $11k
| 0
| 8,578
| 5,081.6016
| null | 7
|
white
| 17.5
| 16
| 0.688965
| 0.396973
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 83
| 4.5
| 100
| 20
| 38.09375
| null | 3.299805
| 0.699951
| 0.799927
| 136
| 7.539062
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,564
| 0
|
83.11597
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 27,727
| 15,532.4844
| null | 18.333328
|
white
| 30.398438
| 34
| 0.599976
| 0.492981
| 1
| 0
| 1
|
no
| 0.7
| 0.5
|
dnr after sadm
| 2
| 53
| 14.5
| 63
| 24
| 36.09375
| 103.32812
| 3.199707
| 0.799927
| 1.099854
| 145
| 7.479492
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 135
| 1
|
70.21997
|
female
| 1
| 4
|
Coma
|
Coma
| 1
| 14
|
>$50k
| 0
| 14,317
| 6,209.9922
| null | 49
|
white
| 60.195313
| 90
| 0
| 0
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 3
| 42
| 11.898438
| 108
| 9
| 32.29688
| 54
| 2.199707
| 4.399414
| 2.799805
| 136
| 7.449219
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 4
| 1
|
65.92999
|
male
| 0
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 0
| 88,955
| 50,380.625
| null | 27.25
|
white
| 28.5
| 50
| 0.72998
| 0.646973
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 45
| 57
| 10.5
| 170
| 28
| 38.69531
| 138
| null | null | 1
| 142
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,561
| 0
|
50.97598
|
male
| 0
| 74
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 18
|
under $11k
| 37
| 74,681
| 47,597.1562
| null | 8.25
|
black
| 21.296875
| 15
| 0.753906
| 0.675903
| 1
| 1
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 74
| 82
| 10.099609
| 106
| 26
| 36
| 225
| 2.5
| 0.299988
| 0.899902
| 134
| 7.449219
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.289551
| 1,560
| 0
|
43.047
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 18
| null | 0
| 6,616
| 4,769.8359
| null | 8
| null | 19.097656
| 31
| 0.938965
| 0.894897
| 1
| 0
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 5
| 107
| 9.798828
| 70
| 25
| 35.59375
| 214.28125
| null | null | 1
| 143
| 7.429688
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,560
| 0
|
54.793
|
female
| 1
| 27
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 48,801
| 29,029.0938
| null | 20.5
|
white
| 30.796875
| 64
| 0.552979
| 0.439941
| 1
| 0
| 0
|
yes
| 0.6
| 0.5
|
dnr after sadm
| 22
| 123
| 0.099991
| 170
| 38
| 39.59375
| null | 2.5
| 0.699951
| 1.099854
| 144
| null | null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 27
| 1
|
59.64398
|
female
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 20,609
| null | null | 37.5
|
hispanic
| 37.898438
| 35
| 0.253967
| 0.148987
| 1
| 0
| 0
|
metastatic
| 0.15
| 0.08
|
dnr after sadm
| 5
| 45
| 6.299805
| 112
| 38
| 37.89844
| 118.32812
| 3.099609
| null | 0.599976
| 138
| 7.30957
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
75.45795
|
female
| 0
| 55
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 207,683
| 103,477.188
| null | 37.5
|
white
| 30
| 56
| 0.554932
| 0.441956
| 15
| 0
| 0
|
no
| null | null |
dnr after sadm
| 9
| 123
| 7.399414
| 101
| 8
| 38.59375
| 79
| 3
| null | 2.199707
| 154
| 7.459961
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,556
| 0
|
75.65198
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 32,199
| 21,257.1094
| null | 47
|
white
| 26.597656
| 25
| 0.635986
| 0.534912
| 16
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 68
| 9.699219
| 125
| 20
| 39.39844
| 132
| null | null | 0.699951
| 139
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.556152
| 4
| 1
|
79.27698
|
female
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 14,304
| 8,597.7031
| null | 18.5
|
white
| 20.597656
| 27
| 0.778931
| 0.646973
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
dnr after sadm
| 1
| 60
| 16.296875
| 100
| 20
| 37.79688
| 311.625
| 3.299805
| 0.699951
| 1.699951
| 135
| 7.399414
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 1,556
| 0
|
73.51996
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 3
| 12
|
under $11k
| 0
| 6,003
| 3,975.2188
| null | 4
|
white
| 17.796875
| 14
| 0.669922
| 0.370972
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.8
|
dnr after sadm
| 3
| 100
| 21.898438
| 80
| 20
| 36.69531
| null | null | 0.699951
| 0.599976
| 136
| 7.439453
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 32
| 1
|
41.52197
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 2
| 11
| null | 0
| 15,020
| 9,517.5469
| null | 10.5
|
white
| 9.798828
| 14
| 0.85791
| 0.68396
| 1
| 1
| 0
|
metastatic
| 0.75
| 0.1
|
no dnr
| 12
| 101
| 6.5
| 72
| 14
| 35.89844
| null | 4
| 0.899902
| 1
| 141
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 97
| 1
|
81.25098
|
female
| 0
| 38
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 100
| 45,228
| 32,094.3125
| null | 17
|
white
| 24.398438
| 49
| 0.21698
| 0.069992
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 1
| 67
| 4.399414
| 63
| 38
| 36.69531
| 257.125
| 3.299805
| 0.399963
| 3.399902
| 144
| 7.259766
| null | null | null | null | null |
SIP>=30
| 4.545898
| 78
| 1
|
46.59497
|
male
| 0
| 17
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 15
|
under $11k
| 0
| 21,756
| 11,337.4766
| null | 11.333328
|
white
| 42.09375
| 66
| 0.359985
| 0.167999
| 2
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 7
| 57
| 12.099609
| 118
| 24
| 36.09375
| 328.5625
| 2.899902
| 36.5
| 5.399414
| 136
| 7.40918
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,551
| 0
|
77.52496
|
male
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
| null | 0
| 16,099
| 8,107.6133
| null | 17
|
white
| 34.09375
| 63
| 0.416992
| 0.296997
| 1
| 0
| 0
|
yes
| 0.9
| 0.7
|
no dnr
| 10
| 110
| 0.899902
| 110
| 28
| 36.09375
| 270
| 2.899902
| 3.799805
| 1.699951
| 136
| 7.479492
| null | null | null | null | 0
| null | 0
| 246
| 1
|
56.71997
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 22
| null | 0
| 16,069
| 6,561.6797
| null | 16
|
white
| 26.296875
| 45
| 0.80188
| 0.736938
| 1
| 0
| 0
|
no
| 0.99
| 0.9
|
no dnr
| 8
| 135
| 11.099609
| 142
| 68
| 37.79688
| 205
| 3.399902
| 1.599854
| 1.099854
| 142
| 7.449219
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,550
| 0
|
70.73499
|
male
| 0
| 58
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
>$50k
| 0
| 61,059
| 35,104.8438
| null | 6.75
|
white
| 24.199219
| 36
| 0.725952
| 0.641968
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 58
| 61
| 7.099609
| 52
| 28
| 37.89844
| 151
| null | null | 1.599854
| 134
| 7.369141
| null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 1,236
| 1
|
77.53296
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 10,496
| 5,027.7578
| null | 19
|
white
| 23.199219
| 57
| 0.747925
| 0.602905
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 67
| 26.097656
| 132
| 42
| 36.19531
| 223.78125
| 3.899902
| null | 1
| 138
| 7.329102
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,550
| 0
|
85.20496
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 21,089
| 11,513.1719
| null | 17
|
white
| 22.097656
| 36
| 0.552979
| 0.35498
| 11
| 0
| 0
|
yes
| 0.9
| 0.5
|
no dnr
| 7
| 56
| 5.199219
| 70
| 25
| 36.09375
| 175.5
| null | null | 1
| 140
| 7.359375
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 299
| 1
|
47.61398
|
female
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 0
| 11,252
| 4,251.1133
| null | 13
|
white
| 18.597656
| 18
| 0.898926
| 0.861938
| 2
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 5
| 63
| 6.699219
| 72
| 24
| 37.79688
| 137.5
| null | 0.5
| 0.899902
| 143
| 7.569336
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,547
| 0
|
75.78094
|
female
| 0
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 30,913
| 15,681.8906
| null | 20.5
|
white
| 36.5
| 62
| 0.235992
| 0.134979
| 14
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 2
| 51
| 58.195313
| 59
| 26
| 35.29688
| 197.5
| 3.099609
| 2.199707
| 2
| 132
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.98291
| 49
| 1
|
74.95697
|
male
| 1
| 48
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 131,184
| 100,893.625
| null | 39.25
|
white
| 23.5
| 30
| 0.751953
| 0.67395
| 3
| 0
| 0
|
no
| 0.8
| 0.8
|
dnr after sadm
| 18
| 123
| 10.199219
| 80
| 6
| 36.29688
| 121.65625
| null | null | 1.5
| 138
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 2.132813
| 48
| 1
|
74.32196
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 3,623
| 2,212.6562
| null | 5
|
white
| 15.298828
| 36
| 0.882935
| 0.804932
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 97
| 11.5
| 70
| 32
| 37.09375
| 400
| 4
| 0.699951
| 2
| 142
| 7.489258
| null | null | null | 2
| 1
|
SIP>=30
| 1
| 234
| 1
|
64.19696
|
female
| 1
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 104,074
| 35,145.8438
| null | 41.5
|
white
| 36.898438
| 39
| 0.465942
| 0.346985
| 1
| 0
| 0
|
yes
| 0.75
| 0.6
|
dnr after sadm
| 9
| 46
| 19.199219
| 123
| 12
| 39.09375
| 175
| 3.599609
| null | 0.299988
| 137
| 7.379883
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 34
| 1
|
58.65799
|
male
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 21,228
| 11,682.9922
| null | 11
|
white
| 13.599609
| 18
| 0.932983
| 0.885986
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 17
| 73
| 11.099609
| 80
| 20
| 35.59375
| 196.65625
| 4.399414
| null | 1.099854
| 141
| 7.359375
| null | null | null | 1
| 0
|
SIP>=30
| 0
| 153
| 1
|
93.34998
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 9
| 22,396
| 12,064.6797
| null | 12
|
white
| 19.699219
| 28
| 0.741943
| 0.661987
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 17
| 70
| 7.5
| 58
| 8
| 36.09375
| 325
| null | 1.699951
| 1.699951
| 143
| 7.369141
| null | null | null | null | null | null | 4.532227
| 462
| 1
|
67.10199
|
male
| 1
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
| null | 0
| 26,499
| 16,922.2969
| null | 13
|
white
| 21.898438
| 29
| 0.833984
| 0.728882
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 22
| 117
| 11.798828
| 100
| 20
| 36.09375
| 368
| 4
| 0.799927
| 2.799805
| 135
| 7.519531
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 22
| 1
|
51.45499
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
under $11k
| 0
| 36,074
| 15,445.6406
| null | 31.333328
|
white
| 25
| 26
| 0.815918
| 0.754883
| 3
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 14
| 67
| 6.799805
| 62
| 8
| 36.09375
| 141.40625
| 2.599609
| 1.399902
| 0.599976
| 134
| 7.389648
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 1,543
| 0
|
65.08698
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 5,422
| 2,610.7871
| null | 14
|
white
| 15.398438
| 13
| 0.902954
| 0.836914
| 1
| 1
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 5
| 83
| 7.799805
| 100
| 20
| 37.79688
| 648.125
| null | null | 1.199951
| 136
| 7.40918
| null | null | null | null | null | null | 2.595703
| 1,543
| 0
|
84.48199
|
male
| 1
| 106
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 6
|
$11-$25k
| 0
| 227,626
| 151,603
| null | 25.75
|
white
| 22.097656
| 29
| 0.679932
| 0.509888
| 3
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 106
| 107
| 16.398438
| 120
| 32
| 37.79688
| 223
| null | null | 1.299805
| 146
| 7.389648
| null | null | null | 1
| 0
|
adl>=4 (>=5 if sur)
| 0
| 106
| 1
|
42.82797
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
under $11k
| 0
| 16,096
| 8,934.75
| null | 40
|
black
| 52
| 92
| 0.256958
| 0.151978
| 1
| 0
| 0
|
no
| 0
| 0
|
no dnr
| 4
| 40
| 32.195313
| 135
| 37
| 35.69531
| 125
| 2.199707
| 5.699219
| 8.298828
| 143
| 7.269531
| null | null | null | null | null |
<2 mo. follow-up
| 1.983154
| 4
| 1
|
80.45697
|
female
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
| null | 0
| 12,819
| 7,515.3398
| null | 23.5
|
white
| 48.59375
| 71
| 0.056
| 0.018997
| 1
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 2
| 46
| 0.099991
| 128
| 35
| 36.29688
| 190
| 3.399902
| 2.099609
| 0.899902
| 127
| 7.469727
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 10
| 1
|
58.28598
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 34,635
| 20,541.2812
| null | 46
|
white
| 47.59375
| 72
| 0.231995
| 0.131989
| 3
| 1
| 0
|
no
| null | null |
dnr after sadm
| 3
| 43
| 35.5
| 120
| 14
| 40.39844
| 106.65625
| 2.099609
| null | 2.399902
| 131
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 2.449219
| 3
| 1
|
67.01196
|
male
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 94,528
| 71,583.0625
| null | 45.666657
|
white
| 32.09375
| 54
| 0.563965
| 0.451965
| 10
| 1
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 19
| 55
| 21.398438
| 120
| 12
| 38.59375
| 186
| null | null | 4.199219
| 140
| 7.359375
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
70.03998
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 12,519
| 7,553.4453
| null | 6.5
|
white
| 15.099609
| 21
| 0.73291
| 0.462952
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 77
| 5.799805
| 70
| 25
| 36.09375
| null | 3.799805
| 1.399902
| 0.699951
| 143
| null | null | null | null | null | null | null | 2.902344
| 151
| 1
|
99.28497
|
male
| 1
| 53
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 17
| null | 0
| 118,924
| 35,281.5938
| null | 34.5
|
white
| 33.398438
| 43
| 0.389954
| 0.19397
| 1
| 0
| 1
|
no
| 0.3
| 0.2
|
no dnr
| 53
| 45
| 13.199219
| 70
| 10
| 36.39844
| 212.5
| null | 1.699951
| 2.299805
| 132
| 7.489258
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 53
| 1
|
52.504
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 15,466
| 7,561.2266
| null | 13
|
white
| 23.097656
| 22
| 0.855957
| 0.762939
| 1
| 0
| 0
|
yes
| 1
| 0.95
|
no dnr
| 11
| 71
| 19.398438
| 140
| 24
| 36.09375
| 288
| null | null | 0.899902
| 143
| 7.329102
| null | null | null | 2
| 1
|
no(M2 and SIP pres)
| 1
| 927
| 1
|
68.99097
|
female
| 1
| 8
|
Colon Cancer
|
Cancer
| 1
| 6
|
$25-$50k
| 0
| 9,864
| 6,236.082
| null | 18
|
white
| 32.898438
| 36
| 0.463989
| 0.148987
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 1
| 53
| 7.699219
| 72
| 10
| 35.79688
| null | 2.5
| 0.599976
| 1.099854
| 137
| null | null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 8
| 1
|
59.49298
|
female
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 40,197
| 20,480.5469
| null | 18
|
black
| 25.597656
| 40
| 0.802979
| 0.736938
| 1
| 0
| 0
|
no
| 1
| 0.8
|
no dnr
| 26
| 137
| 18.097656
| 119
| 32
| 35.79688
| 273.4375
| 5
| 0.599976
| 1.5
| 138
| 7.359375
| null | null | null | 0
| 0
| null | 0
| 668
| 1
|
86.61694
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 16,228
| 8,260.2891
| null | 16.5
|
white
| 25.398438
| 42
| 0.694946
| 0.603882
| 1
| 0
| 0
|
no
| 1
| 0.7
|
no dnr
| 13
| 53
| 12.699219
| 66
| 32
| 36.09375
| 280
| 4.5
| 1.799805
| 1.299805
| 143
| 7.40918
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,494
| 1
|
26.56
|
female
| 1
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
| null | 0
| 97,294
| 45,422.125
| null | 54.666657
|
white
| 35.398438
| 34
| 0.396973
| 0.277954
| 6
| 0
| 0
|
yes
| 0.2
| 0.2
|
dnr after sadm
| 15
| 49
| 5.5
| 118
| 10
| 36.39844
| 137.5
| 2.199707
| 1.299805
| 0.699951
| 144
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 2.128906
| 15
| 1
|
51.39999
|
male
| 0
| 15
|
Coma
|
Coma
| 1
| 12
|
$25-$50k
| 0
| 28,600
| 11,534.4531
| null | 29
|
white
| 38.296875
| 46
| 0.441956
| 0.367981
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 15
| 47
| 4.199219
| 126
| 10
| 38.29688
| 88
| null | 2
| 0.599976
| 133
| 7.449219
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,531
| 0
|
70.62598
|
female
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 6
| 12
|
under $11k
| 0
| 82,196
| 63,520.0625
| null | 24.75
|
white
| 21.296875
| 32
| 0.779907
| 0.707886
| 8
| 1
| 0
|
no
| 0.8
| 0.2
|
no dnr
| 29
| 71
| 7.099609
| 62
| 24
| 36.69531
| 266.625
| null | 0.399963
| 3.899902
| 141
| 7.489258
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,114
| 1
|
44.17499
|
male
| 0
| 35
|
Colon Cancer
|
Cancer
| 2
| 13
|
$11-$25k
| 26
| 45,066
| 26,888.6406
| null | 19.5
|
white
| 37.398438
| 23
| 0.293945
| 0.047997
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.3
|
no dnr
| 35
| 66
| 9.398438
| 116
| 24
| 38.89844
| 504.75
| 2.099609
| 1
| 0.599976
| 134
| 7.439453
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 51
| 1
|
75.01996
|
male
| 0
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 0
| 24,165
| 8,863.8125
| null | 39.5
|
white
| 27.398438
| 37
| 0.527954
| 0.411987
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
no dnr
| 12
| 57
| 5.099609
| 51
| 10
| 38
| 150
| 4.099609
| 0.899902
| 1.699951
| 144
| 7.149414
| null | null | null | 0
| 3
|
<2 mo. follow-up
| 3
| 33
| 1
|
69.09796
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 26
| 18,468
| 13,271.6875
| null | 19
|
white
| 26.296875
| 28
| 0.629883
| 0.526978
| 3
| 0
| 1
|
no
| 0.95
| 0.85
|
no dnr
| 7
| 63
| 7.399414
| 100
| 9
| 36.29688
| 113
| 2.899902
| 1
| 1.299805
| 135
| 7.489258
| null | null | null | null | null | null | 4.816406
| 1,528
| 0
|
79.66095
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
| null | 0
| 26,312
| 13,002.9297
| null | 18
|
white
| 17.796875
| 29
| 0.830933
| 0.773926
| 2
| 0
| 0
|
no
| 0.93
| 0.85
|
no dnr
| 8
| 54
| 10
| 67
| 16
| 38
| 236.71875
| 2.5
| null | 0.899902
| 142
| 7.449219
| null | null | null | 0
| 0
| null | 0
| 1,527
| 0
|
81.23798
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$11-$25k
| 0
| 3,806
| 2,219.1094
| null | 7
|
white
| 22.296875
| 20
| 0.772949
| 0.637939
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 4
| 83
| 11
| 60
| 20
| 35.59375
| 336
| null | null | 1.899902
| 142
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 204
| 1
|
71.30695
|
female
| 0
| 18
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 31,908
| 23,415.7656
| null | 31.666656
|
white
| 27.699219
| 44
| 0.664917
| 0.490967
| 1
| 1
| 0
|
yes
| 0.5
| 0.4
|
no dnr
| 18
| 64
| 15.898438
| 72
| 30
| 39.19531
| 68
| null | null | 1.199951
| 133
| 7.469727
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 207
| 1
|
82.39294
|
male
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 9
|
$11-$25k
| 0
| 9,332
| 5,003.9336
| null | 8
|
white
| 16.296875
| 44
| 0.80896
| 0.745972
| 1
| 1
| 0
|
yes
| 0.95
| 0.8
|
no dnr
| 8
| 73
| 8.898438
| 70
| 25
| 37.79688
| 188
| 3.199707
| null | 1.099854
| 142
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,524
| 0
|
71.00098
|
female
| 1
| 16
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null |
$11-$25k
| 0
| 20,870
| 11,380.0078
| null | 15
|
white
| 27.398438
| 57
| 0.658936
| 0.483948
| 1
| 0
| 0
|
yes
| 0.3
| 0.1
|
dnr after sadm
| 2
| 103
| 6.699219
| 70
| 30
| 37.79688
| 100
| 3.099609
| 0.299988
| 1.599854
| 132
| 7.459961
| null | null | null | 6
| 6
|
<2 mo. follow-up
| 6
| 16
| 1
|
91.03894
|
male
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 10
|
$11-$25k
| 0
| 27,902
| 12,191.4844
| null | 13
|
white
| 27.898438
| 41
| 0.506958
| 0.305969
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 3
| 97
| 9.599609
| 120
| 50
| 37.19531
| 175.5
| 3.299805
| null | 1.299805
| 144
| 7.379883
| null | null | null | null | 3
|
SIP>=30
| 3
| 87
| 1
|
48.78
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 10
|
under $11k
| 0
| 10,689
| 6,053.1328
| null | 13
|
white
| 22.898438
| 21
| 0.619995
| 0.305969
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 61
| 5
| 120
| 24
| 36.89844
| null | 3.199707
| 0.299988
| 0.699951
| 145
| 7.469727
| null | null | null | null | 0
|
SIP>=30
| 0
| 84
| 1
|
76.18597
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
under $11k
| 0
| 25,469
| 20,858.3125
| null | 16
|
black
| 33.398438
| 47
| 0.482971
| 0.36499
| 7
| 0
| 0
|
no
| 0.65
| 0.5
|
dnr after sadm
| 1
| 54
| 10.398438
| 71
| 24
| 35
| 432
| null | 0.5
| 2.399902
| 125
| 7.509766
| null | null | null | 7
| 2
|
<2 mo. follow-up
| 2
| 37
| 1
|
84.62994
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 9
| null | 9
| 6,414
| 3,839.3555
| null | 13
|
white
| 20.199219
| 36
| 0.717896
| 0.560913
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr before sadm
| -1
| 80
| 9.898438
| 60
| 30
| 36.09375
| 190.46875
| 3.599609
| null | 1.199951
| 138
| 7.449219
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 24
| 1
|
93.62897
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 9
| 4,975
| 2,718.4961
| null | 8
|
white
| 17.296875
| 25
| 0.773926
| 0.639893
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
dnr after sadm
| 1
| 67
| 5.799805
| 70
| 20
| 36.09375
| null | null | null | 0.899902
| 132
| 7.389648
| null | null | null | null | null | null | 4.31543
| 624
| 1
|
86.18799
|
female
| 1
| 23
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 26,902
| 16,868.9062
| null | 9.666664
|
black
| 27.398438
| 27
| 0.375
| 0.087997
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 2
| 100
| 8.699219
| 100
| 25
| 36.09375
| null | 3
| 0.399963
| 0.699951
| 131
| null | null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 23
| 1
|
76.53894
|
female
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 56,726
| 19,535.5
| null | 33.666657
|
white
| 31
| 50
| 0.416992
| 0.297974
| 3
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 11
| 50
| 9.798828
| 48
| 42
| 38
| 170
| 3.199707
| null | 0.699951
| 134
| 7.419922
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 16
| 1
|
80.79095
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 21,055
| 10,767.7969
| null | 10
|
white
| 14.199219
| 15
| 0.820923
| 0.708984
| 6
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 8
| 83
| 12.898438
| 80
| 20
| 38
| 390
| null | null | 0.899902
| 144
| 7.389648
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,521
| 0
|
49.85397
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 31,619
| 9,491.9141
| null | 35.333313
|
white
| 39.296875
| 39
| 0.493958
| 0.375977
| 1
| 0
| 0
|
yes
| 0.3
| 0.3
|
no dnr
| 14
| 43
| 11.398438
| 114
| 10
| 39.29688
| 154
| 2.299805
| 0.599976
| 0.299988
| 147
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.375488
| 54
| 1
|
94.10797
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 9
| 21,424
| 12,836.1719
| null | 13.333328
|
white
| 13.199219
| 24
| 0.836914
| 0.781982
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 70
| 9.298828
| 80
| 20
| 36.69531
| 295
| null | 0.399963
| 1.099854
| 140
| 7.299805
| null | null | null | 4
| null |
<2 mo. follow-up
| 3.183199
| 27
| 1
|
97.83997
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 49,040
| 36,014.4375
| null | 39.5
|
white
| 24.097656
| 47
| 0.594971
| 0.487
| 7
| 0
| 1
|
no
| 0.2
| 0.2
|
dnr after sadm
| 6
| 103
| 8.199219
| 105
| 48
| 37.59375
| 124
| 2
| 1
| 1.299805
| 142
| 7.469727
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
66.51294
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 8,567
| 6,116.7656
| null | 20
|
white
| 22.5
| 19
| 0.778931
| 0.707886
| 1
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 7
| 72
| 8.898438
| 60
| 16
| 36.19531
| 140
| 5.199219
| 1.799805
| 1.099854
| 137
| 7.359375
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 803
| 1
|
29.618
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 0
| 69,945
| 27,965.0312
| null | 25
|
white
| 22
| 25
| 0.881958
| 0.840942
| 13
| 0
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 23
| 58
| 6.5
| 124
| 8
| 38.09375
| 353.3125
| 3.599609
| null | 0.599976
| 136
| 7.449219
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,512
| 0
|
72.10095
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
$11-$25k
| 0
| 4,571
| 2,801.9727
| null | 7
|
white
| 19.898438
| 45
| 0.840942
| 0.73999
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 120
| 11.398438
| 80
| 25
| 35.59375
| null | 4.199219
| 0.599976
| 2.799805
| 139
| null | null | null | null | 2
| null | null | 1.839
| 833
| 1
|
43.16998
|
male
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 97,562
| 64,663.4688
| null | 33.5
|
white
| 27.5
| 35
| 0.807983
| 0.743896
| 3
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 34
| 60
| 12.398438
| 58
| 12
| 39.59375
| 97.14062
| null | 0.599976
| 1.5
| 146
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,514
| 0
|
80.01599
|
female
| 1
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 105,850
| 78,684
| null | 38.25
|
white
| 31.296875
| 46
| 0.506958
| 0.389954
| 9
| 1
| 0
|
no
| 0.05
| 0.000125
|
dnr before sadm
| -3
| 62
| 13
| 62
| 8
| 37.79688
| 153.3125
| null | null | 4.5
| 128
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 31
| 1
|
54.26099
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 13,516
| 6,553.5938
| null | 19
|
black
| 32.59375
| 56
| 0.420959
| 0.301941
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 4
| 53
| 19.597656
| 74
| 22
| 37.69531
| 386.625
| 2.599609
| 8.599609
| 2.899902
| 149
| 7.359375
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 5
| 1
|
54.33499
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 9
| 18,839
| 7,886.2734
| null | 22
|
black
| 35.898438
| 43
| 0.56897
| 0.457947
| 2
| 1
| 0
|
no
| 1
| 1
|
no dnr
| 12
| 45
| 10.798828
| 118
| 28
| 39.09375
| 490.4375
| 2.699707
| null | 1.899902
| 153
| 7.40918
| null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 1,021
| 1
|
85.16095
|
female
| 1
| 25
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$25-$50k
| 9
| 27,344
| 17,588.2812
| null | 11.666664
|
white
| 28.597656
| 52
| 0.587891
| 0.395996
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 5
| 57
| 7
| 56
| 20
| 34.79688
| 396
| 3.399902
| 1.5
| 2.899902
| 142
| 7.419922
| null | null | null | 5
| null |
<2 mo. follow-up
| 3.855299
| 25
| 1
|
52.19199
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 0
| 20,742
| 10,266.4219
| null | 11.666664
|
white
| 18.199219
| 31
| 0.900879
| 0.86499
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 16
| 103
| 9.599609
| 66
| 22
| 36
| 403.6875
| 3.299805
| 0.5
| 12.398438
| 143
| 7.379883
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,059
| 1
|
74.72095
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 0
| 6,934
| 3,570.0644
| null | 9
|
white
| 13
| 27
| 0.899902
| 0.862915
| 1
| 1
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 6
| 120
| 8.199219
| 80
| 20
| 37.5
| 309
| 4.399414
| 0.299988
| 1.5
| 142
| 7.279297
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,507
| 0
|
88.32898
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
| null | 0
| 21,473
| 7,042.2812
| null | 45.5
|
white
| 34.398438
| 35
| 0.428955
| 0.309998
| 2
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 8
| 40
| 13.398438
| 55
| 10
| 37.19531
| 192.5
| 2.5
| null | 1.399902
| 133
| 7.489258
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.